Ingunn M. Stromnes

5.8k total citations · 1 hit paper
44 papers, 3.8k citations indexed

About

Ingunn M. Stromnes is a scholar working on Immunology, Oncology and Epidemiology. According to data from OpenAlex, Ingunn M. Stromnes has authored 44 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Immunology, 27 papers in Oncology and 4 papers in Epidemiology. Recurrent topics in Ingunn M. Stromnes's work include CAR-T cell therapy research (19 papers), Immunotherapy and Immune Responses (18 papers) and Immune Cell Function and Interaction (17 papers). Ingunn M. Stromnes is often cited by papers focused on CAR-T cell therapy research (19 papers), Immunotherapy and Immune Responses (18 papers) and Immune Cell Function and Interaction (17 papers). Ingunn M. Stromnes collaborates with scholars based in United States, Germany and Japan. Ingunn M. Stromnes's co-authors include Joan Goverman, Philip D. Greenberg, Kristin G. Anderson, Sunil R. Hingorani, Robert A. Harris, Denny Liggitt, Kim J. Hasenkrug, Karin E. Peterson, Ronald J. Messer and Michihiro Iwashiro and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Ingunn M. Stromnes

43 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Obstacles Posed by the Tumor Microenvironment to T cell Activity: A Case for Synergistic Therapies

2017 509 citations Kristin G. Anderson, Ingunn M. Stromnes et al. Cancer Cell profile →

Peers

Ingunn M. Stromnes

IMMUN

ONCOL

PFM

NEURO

Jody L. Baron United States

Dirk Baumjohann Germany

Jason A. Hackney United States

Paul R. Walker Switzerland

Roberta Castriconi Italy

Miyuki Nishimura Japan

Hervé Luche France

Wayne To United States

Byoung S. Kwon South Korea

Kutlu G. Elpek United States

Jody L. Baron United States

Ingunn M. Stromnes

3.5k ×1.4

IMMUN

1.1k ×0.7

ONCOL

879 ×1.3

301 ×0.7

PFM

248 ×0.8

NEURO

Citations per year, relative to Ingunn M. Stromnes Ingunn M. Stromnes (= 1×) peers Jody L. Baron

Countries citing papers authored by Ingunn M. Stromnes

Since Specialization

Citations

This map shows the geographic impact of Ingunn M. Stromnes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingunn M. Stromnes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingunn M. Stromnes more than expected).

Fields of papers citing papers by Ingunn M. Stromnes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingunn M. Stromnes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingunn M. Stromnes. The network helps show where Ingunn M. Stromnes may publish in the future.

Co-authorship network of co-authors of Ingunn M. Stromnes

This figure shows the co-authorship network connecting the top 25 collaborators of Ingunn M. Stromnes. A scholar is included among the top collaborators of Ingunn M. Stromnes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingunn M. Stromnes. Ingunn M. Stromnes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schmiechen, Zoe C., Adam L. Burrack, Nicholas J. Maurice, et al.. (2025). IL-15 Complex Enhances Agonistic Anti-CD40 + Anti-PDL1 by Correcting the T-bet to Tox Ratio in CD8+ T cells Infiltrating Pancreatic Ductal Adenocarcinoma. Cancer Immunology Research. 13(6). 847–866. 2 indexed citations

Alcolea, Maria P., Direna Alonso‐Curbelo, Chiara Ambrogio, et al.. (2024). Cancer Hallmarks: Piecing the Puzzle Together. Cancer Discovery. 14(4). 674–682. 7 indexed citations

Spartz, Ellen J., Walker S. Lahr, Yun You, et al.. (2023). Germline T cell receptor exchange results in physiological T cell development and function. Nature Communications. 14(1). 528–528. 2 indexed citations

Patterson, Michael T., Adam L. Burrack, Yingzheng Xu, et al.. (2023). Tumor-specific CD4 T cells instruct monocyte fate in pancreatic ductal adenocarcinoma. Cell Reports. 42(7). 112732–112732. 24 indexed citations

Burrack, Adam L., Zoe C. Schmiechen, Michael T. Patterson, et al.. (2022). Distinct myeloid antigen-presenting cells dictate differential fates of tumor-specific CD8+ T cells in pancreatic cancer. JCI Insight. 7(7). 11 indexed citations

Burrack, Adam L., Ellen J. Spartz, Zoe C. Schmiechen, et al.. (2021). CD40 Agonist Overcomes T Cell Exhaustion Induced by Chronic Myeloid Cell IL-27 Production in a Pancreatic Cancer Preclinical Model. The Journal of Immunology. 206(6). 1372–1384. 20 indexed citations

Schmiechen, Zoe C. & Ingunn M. Stromnes. (2021). Mechanisms Governing Immunotherapy Resistance in Pancreatic Ductal Adenocarcinoma. Frontiers in Immunology. 11. 613815–613815. 32 indexed citations

Cole, Kathryn, Quan P. Ly, Michael A. Hollingsworth, et al.. (2020). Comparative phenotypes of peripheral blood and spleen cells from cancer patients. International Immunopharmacology. 85. 106655–106655. 5 indexed citations

Anderson, Kristin G., Valentin Voillet, Breanna M. Bates, et al.. (2019). Engineered Adoptive T-cell Therapy Prolongs Survival in a Preclinical Model of Advanced-Stage Ovarian Cancer. Cancer Immunology Research. 7(9). 1412–1425. 27 indexed citations

10.

Stromnes, Ingunn M., Adam L. Burrack, Ayaka Hulbert, et al.. (2019). Differential Effects of Depleting versus Programming Tumor-Associated Macrophages on Engineered T Cells in Pancreatic Ductal Adenocarcinoma. Cancer Immunology Research. 7(6). 977–989. 52 indexed citations

11.

Burrack, Adam L., et al.. (2019). Combination PD-1 and PD-L1 Blockade Promotes Durable Neoantigen-Specific T Cell-Mediated Immunity in Pancreatic Ductal Adenocarcinoma. Cell Reports. 28(8). 2140–2155.e6. 64 indexed citations

12.

Stromnes, Ingunn M., Ayaka Hulbert, Robert H. Pierce, Philip D. Greenberg, & Sunil R. Hingorani. (2017). T-cell Localization, Activation, and Clonal Expansion in Human Pancreatic Ductal Adenocarcinoma. Cancer Immunology Research. 5(11). 978–991. 148 indexed citations

13.

Anderson, Kristin G., Ingunn M. Stromnes, & Philip D. Greenberg. (2017). Obstacles Posed by the Tumor Microenvironment to T cell Activity: A Case for Synergistic Therapies. Cancer Cell. 31(3). 311–325. 509 indexed citations breakdown →

14.

Stromnes, Ingunn M., Thomas M. Schmitt, Ayaka Hulbert, et al.. (2015). T Cells Engineered against a Native Antigen Can Surmount Immunologic and Physical Barriers to Treat Pancreatic Ductal Adenocarcinoma. Cancer Cell. 28(5). 638–652. 151 indexed citations

15.

Stromnes, Ingunn M., J. Scott Brockenbrough, Kamel Izeradjene, et al.. (2014). Targeted depletion of an MDSC subset unmasks pancreatic ductal adenocarcinoma to adaptive immunity. Gut. 63(11). 1769–1781. 255 indexed citations

16.

Pierson, Emily, Ingunn M. Stromnes, & Joan Goverman. (2013). B Cells Promote Induction of Experimental Autoimmune Encephalomyelitis by Facilitating Reactivation of T Cells in the Central Nervous System. The Journal of Immunology. 192(3). 929–939. 75 indexed citations

17.

Stromnes, Ingunn M., et al.. (2010). Abrogating Cbl-b in effector CD8+ T cells improves the efficacy of adoptive therapy of leukemia in mice. Journal of Clinical Investigation. 120(10). 3722–3734. 73 indexed citations

18.

Stromnes, Ingunn M., et al.. (2008). Differential regulation of central nervous system autoimmunity by TH1 and TH17 cells. Nature Medicine. 14(3). 337–342. 495 indexed citations

19.

Stromnes, Ingunn M. & Joan Goverman. (2006). Active induction of experimental allergic encephalomyelitis. Nature Protocols. 1(4). 1810–1819. 466 indexed citations

20.

Perchellet, Antoine, Ingunn M. Stromnes, Jennifer M. Pang, & Joan Goverman. (2004). CD8+ T cells maintain tolerance to myelin basic protein by 'epitope theft'. Nature Immunology. 5(6). 606–614. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact